tradingkey.logo

Mainz Biomed NV

MYNZ
View Detailed Chart

1.375USD

+0.045+3.38%
Market hours ETQuotes delayed by 15 min
3.19MMarket Cap
LossP/E TTM

Mainz Biomed NV

1.375

+0.045+3.38%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.38%

5 Days

-32.60%

1 Month

-3.85%

6 Months

-80.13%

Year to Date

-68.17%

1 Year

-90.45%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts
BUY
Current Rating
14.000
Target Price
952.63%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

69
Total
7
Median
8
Average
Company name
Ratings
Analysts
Mainz Biomed NV
MYNZ
1
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Natera Inc
NTRA
22
1
2
3
...
14

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(7)
Neutral(2)
Buy(0)
Indicators
Sell(1)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.082
Neutral
RSI(14)
33.016
Neutral
STOCH(KDJ)(9,3,3)
9.598
Oversold
ATR(14)
0.223
Low Volatility
CCI(14)
-264.935
Oversold
Williams %R
96.842
Oversold
TRIX(12,20)
0.516
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.740
Sell
MA10
1.893
Sell
MA20
1.847
Sell
MA50
1.806
Sell
MA100
2.591
Sell
MA200
4.840
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Ticker SymbolMYNZ
CompanyMainz Biomed NV
CEOMr. Guido Baechler
Websitehttps://www.mainzbiomed.com/
KeyAI